相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metformin Activates AMP Kinase through Inhibition of AMP Deaminase
Jiangyong Ouyang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Differential Cardiac Remodeling in Preload Versus Afterload
Karl Toischer et al.
CIRCULATION (2010)
Adverse Bioenergetic Consequences of Na+-Ca2+ Exchanger-Mediated Ca2+ Influx in Cardiac Myocytes
Michael Kohlhaas et al.
CIRCULATION (2010)
Heart Disease and Stroke Statistics-2010 Update A Report From the American Heart Association
Donald Lloyd-Jones et al.
CIRCULATION (2010)
Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake via p38α MAP Kinase-Mediated, Nitric Oxide-Dependent Mechanisms in Conscious Dogs With Dilated Cardiomyopathy
Siva Bhashyam et al.
CIRCULATION-HEART FAILURE (2010)
On energy circuits in the failing myocardium
Joanne S. Ingwall et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
High-energy phosphotransfer in the failing mouse heart: role of adenylate kinase and glycolytic enzymes
Dunja Aksentijevic et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Progressive loss of creatine maintains a near normal Delta G similar to(ATP) in transgenic mouse hearts with cardiomyopathy caused by overexpressing Gs alpha
Weiqun Shen et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Targeted GLUT-4 deficiency in the heart induces cardiomyocyte hypertrophy and impaired contractility linked with Ca2+ and proton flux dysregulation
Andrea A. Domenighetti et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Myocardial Fatty Acid Metabolism in Health and Disease
Gary D. Lopaschuk et al.
PHYSIOLOGICAL REVIEWS (2010)
Energy metabolism in heart failure and remodelling
Joanne S. Ingwall
CARDIOVASCULAR RESEARCH (2009)
Metformin Prevents Progression of Heart Failure in Dogs Role of AMP-Activated Protein Kinase
Hideyuki Sasaki et al.
CIRCULATION (2009)
Activation and Signaling by the AMP-Activated Protein Kinase in Endothelial Cells
Beate Fisslthaler et al.
CIRCULATION RESEARCH (2009)
Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart Failure
Susheel Gundewar et al.
CIRCULATION RESEARCH (2009)
AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease
Aaron K. F. Wong et al.
CLINICAL SCIENCE (2009)
The Adrenergic-Fatty Acid Load in Heart Failure
Lionel H. Opie et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
More than bricks and mortar: Comments on protein and amino acid metabolism in the heart
Heinrich Taetrneyer et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways
Kiwon Ban et al.
CIRCULATION (2008)
AMP-activated protein kinase control of energy metabolism in the ischemic heart
G. D. Lopaschuk
INTERNATIONAL JOURNAL OF OBESITY (2008)
Insulin-resistant cardiomyopathy
Ronald M. Witteles et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease
D. Grahame Hardie
FEBS LETTERS (2008)
Return to the fetal gene program protects the stressed heart: a strong hypothesis
Mitra Rajabi et al.
HEART FAILURE REVIEWS (2007)
A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation) study
Christian J. F. Holubarsch et al.
CLINICAL SCIENCE (2007)
Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes - The MERLIN-TIMI 36 randomized trial
David A. Morrow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Mechanisms of disease - The failing heart - An engine out of fuel
Stefan Neubauer
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Malonyl-CoA decarboxylase inhibition as a novel approach to treat ischemic heart disease
Gary D. Lopaschuk et al.
CARDIOVASCULAR DRUGS AND THERAPY (2006)
Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure
Helena Tuunanen et al.
CIRCULATION (2006)
Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy:: Evidence of relationship with insulin resistance and left ventricular dysfunction
Helena Tuunanen et al.
JOURNAL OF CARDIAC FAILURE (2006)
A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure
Gabriele Fragasso et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
AMPK alterations in cardiac physiology and pathology: enemy or ally?
Jason R. B. Dyck et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Trimetazidine improved Ca2+ handling in isoprenaline-mediated myocardial injury of rats
D Meng et al.
EXPERIMENTAL PHYSIOLOGY (2006)
Controversies in Cardiology 4 - Controversies in ventricular remodelling
LH Opie et al.
LANCET (2006)
Metabolic modulation with perhexiline in chronic heart failure - A randomized, controlled trial of short-term use of a novel treatment
L Lee et al.
CIRCULATION (2005)
Increased α2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy
F Ahmad et al.
CIRCULATION (2005)
N488I mutation of the γ2-subunit results in bidirectional changes in AMP-activated protein kinase activity
LQ Zou et al.
CIRCULATION RESEARCH (2005)
Myocardial substrate metabolism in the normal and failing heart
WC Stanley et al.
PHYSIOLOGICAL REVIEWS (2005)
FASTTRACK Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2):: effects on mortality and morbidity
K Malmberg et al.
EUROPEAN HEART JOURNAL (2005)
Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy
P Di Napoli et al.
HEART (2005)
P/O ratios of mitochondrial oxidative phosphorylation
PC Hinkle
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2005)
Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo
AK Saha et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?
M van Bilsen et al.
CARDIOVASCULAR RESEARCH (2004)
The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy
LA Nikolaidis et al.
CARDIOVASCULAR RESEARCH (2004)
Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties
C Antzelevitch et al.
CIRCULATION (2004)
Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy
LA Nikolaidis et al.
CIRCULATION (2004)
Glucose transport in the heart
ED Abel
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial
JGF Cleland et al.
LANCET (2003)
Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes
M Scheuermann-Freestone et al.
CIRCULATION (2003)
Effect of hyperglycemia and fatty acid oxidation inhibition during aerobic conditions and demand-induced ischemia
PN Chavez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Evaluation of left ventricular diastolic function by pulsed Doppler tissue imaging in mice
A Schaefer et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2003)
Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents
BD Lowes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: A report from the Italian Network on Congestive Heart Failure
S Baldasseroni et al.
AMERICAN HEART JOURNAL (2002)
Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy
R Tian et al.
CIRCULATION (2001)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
In vivo effects of uncoupling protein-3 gene disruption on mitochondrial energy metabolism
GW Cline et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Mutations in the γ2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy:: evidence for the central role of energy compromise in disease pathogenesis
E Blair et al.
HUMAN MOLECULAR GENETICS (2001)
Effect of perhexiline and oxfenicine on myocardial function and metabolism during low-flow ischemia/reperfusion in the isolated rat heart
JA Kennedy et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2000)
First clinical trial with etomoxir in patients with chronic congestive heart failure
S Schmidt-Schweda et al.
CLINICAL SCIENCE (2000)
分享论文
